Abstract:Traditional drug discovery approach is based on one drug-one target, that is associated with very lengthy timelines, high costs and very low success rates. Network pharmacology (NP) is a novel method of drug designing, that is based on a multiple-target approach. NP integrates systems such as biology, pharmacology and computational techniques to address the limitations of traditional methods of drug discovery. With help of mapping biological networks, it provides deep insights into biological molecules' interactions and enhances our understanding to the mechanism of drugs, polypharmacology and disease etiology. This review explores the theoretical framework of network pharmacology, discussing the principles and methodologies that enable the construction of drug-target and disease-gene networks. It highlights how data mining, bioinformatics tools and computational models are utilised to predict drug behaviour, repurpose existing drugs and identify novel therapeutic targets. Applications of network pharmacology in the treatment of complex diseases—such as cancer, neurodegenerative disorders, cardiovascular diseases and infectious diseases—are extensively covered, demonstrating its potential to identify multi-target drugs for multifaceted disease mechanisms. Despite the promising results, NP faces challenges due to incomplete and quality of biological data, computational complexities and biological system redundancy. It also faces regulatory challenges in drug approval, demanding revision in regulatory guidelines towards multi-target therapies. Advancements in AI and machine learning, dynamic network modelling and global collaboration can further enhance the efficacy of network pharmacology. This integrative approach has the potential to revolutionise drug discovery, offering new solutions for personalised medicine, drug repurposing and tackling the complexities of modern diseases.

Bridging the gap between target-based and phenotypic-based drug discovery

Advances in Computational Structure-Based Drug Design and Application in Drug Discovery.

Target-based drug discovery: is something wrong?

Recent advances and method development for drug target identification

Target Discovery and Validation in the Post-Genomic Era

Target-based drug discovery: Applications of fluorescence techniques in high throughput and fragment-based screening

Entering the era of computationally driven drug development

Identifying targets for drug discovery using bioinformatics

Molecular hybridization: a powerful tool for multitarget drug discovery

Targeted Therapies and Drug Resistance in Advanced Breast Cancer, Alternative Strategies and the Way beyond

NATURAL PRODUCTS: FROM TRADITIONAL MEDICINE TO LEAD COMPOUNDS FOR DRUG DEVELOPMENT IN THE 21ST CENTURY

Hit me with your best shot: Integrated hit discovery for the next generation of drug targets

Structural biology and bioinformatics in drug design: opportunities and challenges for target identification and lead discovery

Drug discovery and development: introduction to the general public and patient groups

Current Approaches And Strategies Applied In First‐In‐Class Drug Discovery

Harnessing network pharmacology in drug discovery: an integrated approach

Bench to bedside: The ambitious goal of transducing medicinal chemistry from the lab to the clinic

Implementation of functions in R tool in parallel environment

Molecular interaction networks and drug development: Novel approach to drug target identification and drug repositioning

The right tools for the job: the central role for next generation chemical probes and chemistry-based target deconvolution methods in phenotypic drug discovery

Academic drug discovery: Challenges and opportunities